DOF, the world's first company to succeed decellularization with carbon dioxide... Harmless and safe

DOF, ‘Introduction to supercritical nerve processing’ at the Korean Society of Peripheral Nerve Surgery

DOF, 1,500 acellular allogeneic dermal tissue transplants... ‘Zero’ side effects

DOF Inc. expands the human tissue transplant material market with the world's first supercritical technology

DOF begins to target the human tissue transplant material market with the world's first supercritical technology A new product with safety and viability secured through supercritical ‘decellularization’, resulting in rapid growth in related market sales due to the specialized advantages